about
Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's diseaseExpression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin IITemporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutationUnusual structures are present in DNA fragments containing super-long Huntingtin CAG repeatsMethamphetamine toxicity in mice is potentiated by exposure to loud music.Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.Solving the shepherding problem: heuristics for herding autonomous, interacting agents.A Significance Test for Inferring Affiliation Networks from Spatio-Temporal DataIncreased metabolism in the R6/2 mouse model of Huntington's disease.Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's diseaseIdentifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaireExecutive decision-making in the domestic sheep.Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.Beneficial effects of environmental enrichment and food entrainment in the R6/2 mouse model of Huntington's disease.Data-loggers carried on a harness do not adversely affect sheep locomotion.Tensor-based morphometry and stereology reveal brain pathology in the complexin1 knockout mouseCombining comparative proteomics and molecular genetics uncovers regulators of synaptic and axonal stability and degeneration in vivoDelayed Onset and Reduced Cognitive Deficits through Pre-Conditioning with 3-Nitropropionic Acid is Dependent on Sex and CAG Repeat Length in the R6/2 Mouse Model of Huntington's Disease.Huntington's disease mouse models online: high-resolution MRI images with stereotaxic templates for computational neuroanatomyAdaptation to experimental jet-lag in R6/2 mice despite circadian dysrhythmia.Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging.Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.The touchscreen cognitive testing method for rodents: how to get the best out of your rat.Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age.Potential molecular consequences of transgene integration: The R6/2 mouse example.Circadian and sleep disorder in Huntington's disease.Choosing an animal model for the study of Huntington's disease.Large genetic animal models of Huntington's Disease.Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.Characterisation of progressive motor deficits in whisker movements in R6/2, Q175 and Hdh knock-in mouse models of Huntington's disease.Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.Automated detection and characterisation of rumination in sheep using in vivo electrophysiology.Restriction endonuclease TseI cleaves A:A and T:T mismatches in CAG and CTG repeats.Social Behaviour is Impaired in the R6/2 Mouse Model of Huntington’s Disease.The Cambridge MRI database for animal models of Huntington disease.The morphology of human neuroblastoma cell grafts in the kainic acid-lesioned basal ganglia of the rat.Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice.Accelerated Differentiation in Response to Retinoic Acid After Retrovirally Mediated Gene Transfer of GAP-43 into Mouse Neuroblastoma Cells.Voxel-based morphometry with templates and validation in a mouse model of Huntington's disease.Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions.
P50
Q27334872-BB61824E-DC99-4CEC-9687-4059E04C4DC8Q28179222-9D35508D-0458-4967-915A-CE0E4B2DD43FQ28728849-D807BF54-B0AE-4D4F-9EF0-401B8E900DEAQ28742836-54C20BB3-D6E4-4DBA-8C33-02BF51745059Q30329200-30C8CD7A-4C46-44F1-87B1-AB0AEB066171Q30483013-4B7801D1-AF03-4F44-83F6-078B2A8FFE25Q30590895-F32B7B8F-1968-490B-AFDC-67A51D3EA742Q30981584-2EE6B37E-06A8-4058-B29E-8E5E30892E70Q33301810-864E9B48-A62C-40FA-B159-316474267142Q33640990-9C06C21F-8E53-434C-B8FD-8E3DF4C0B332Q33726864-6FD6FCB5-E62C-4F8E-8124-99A711A56055Q33816028-2CA4CA5D-7772-4692-B931-39AF99E196A7Q33857802-AD85F5AC-950B-4667-B368-8DB1AF7918A1Q33935845-FE8AC8E8-C9AE-44FB-99CA-006749AB504BQ33954058-86FD9979-CCA7-4171-940D-CDCF3D15C3ABQ34185958-273758B0-69DD-492B-BAB2-3E80CBA97523Q34404567-54C71B9A-004E-4B51-B5D4-CD9F3BF27DADQ34520437-3D1770A0-EF83-4134-AA57-FEF306E026B0Q34541881-1CB44C95-FD0F-4061-90C2-07A0B90FF164Q34579980-90775380-3648-46F7-9F7A-09401A062528Q35687906-CC1451F7-961F-4621-B45C-88421325D49DQ36722685-799D53A8-402F-4607-BD12-DDDE8DC9F86AQ36826514-27ED94CE-4B87-40A9-B3CF-416186E224A2Q37593054-06FFE349-1DF5-4A8F-85F4-A5F45883D3ADQ37604396-A838D0E3-EA55-497E-B63C-3609EACA2FDAQ38055662-F2471F04-72BF-4CB5-9548-C294DF257DD1Q38139868-F78FDE4A-2BE8-4DED-8933-1EA0A94544FAQ38234080-59A6B130-FD2E-404A-8060-C3D274D1E9CCQ38707732-43232C0C-D401-42B4-B38B-A21B87374C48Q38803794-86B60EA7-F84A-4C2E-B2D3-E56B8A31CFBDQ39357699-9248088A-20D4-4F99-9C51-0267E7E6DA8AQ39745600-489A35E3-238E-4437-B555-3F10B70BF489Q40366678-D224956E-922E-41FF-A60F-197D30EE60A8Q40581269-60E95A09-8428-4B25-823B-36F7793AB79DQ40976521-021E9840-C123-4C7E-8AC5-35156D5D0071Q41320000-F0C80079-E1C1-49FB-A152-D8674F878B1AQ41463771-EBF3ABEF-6343-4ADD-B9AA-886F806C97DCQ41644293-CBDDF12B-A891-4EB1-A6EF-14CB272AE632Q41939500-C16559E5-D413-44E6-B674-F4C8CD3C0C7FQ42444661-B89ABDB9-1F8C-43BE-A3CE-BE56685038D5
P50
name
A Jennifer Morton
@en
type
label
A Jennifer Morton
@en
prefLabel
A Jennifer Morton
@en